| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | adenylate cyclase activator activity | 1.86e-07 | 5 | 54 | 3 | GO:0010856 | |
| GeneOntologyMolecularFunction | type 3 metabotropic glutamate receptor binding | 3.72e-07 | 6 | 54 | 3 | GO:0031800 | |
| GeneOntologyMolecularFunction | adenylate cyclase regulator activity | 1.55e-06 | 9 | 54 | 3 | GO:0010854 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase regulator activity | 2.21e-06 | 10 | 54 | 3 | GO:0030235 | |
| GeneOntologyMolecularFunction | calcium channel inhibitor activity | 5.25e-06 | 13 | 54 | 3 | GO:0019855 | |
| GeneOntologyMolecularFunction | cyclase activator activity | 5.25e-06 | 13 | 54 | 3 | GO:0010853 | |
| GeneOntologyMolecularFunction | titin binding | 6.66e-06 | 14 | 54 | 3 | GO:0031432 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 6.86e-06 | 172 | 54 | 6 | GO:0044325 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 8.51e-06 | 48 | 54 | 4 | GO:0008200 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 1.00e-05 | 50 | 54 | 4 | GO:0016248 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor binding | 1.02e-05 | 16 | 54 | 3 | GO:0035256 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 1.02e-05 | 16 | 54 | 3 | GO:0008179 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 1.09e-05 | 51 | 54 | 4 | GO:0141110 | |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 1.24e-05 | 17 | 54 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | cyclase regulator activity | 1.48e-05 | 18 | 54 | 3 | GO:0010851 | |
| GeneOntologyMolecularFunction | phosphatase activator activity | 2.06e-05 | 20 | 54 | 3 | GO:0019211 | |
| GeneOntologyMolecularFunction | nitric-oxide synthase binding | 2.78e-05 | 22 | 54 | 3 | GO:0050998 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 1.43e-04 | 98 | 54 | 4 | GO:0048306 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 2.14e-04 | 43 | 54 | 3 | GO:0043548 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 4.21e-04 | 54 | 54 | 3 | GO:0005246 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 9.63e-04 | 162 | 54 | 4 | GO:0099106 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 1.23e-03 | 78 | 54 | 3 | GO:0043539 | |
| GeneOntologyMolecularFunction | channel regulator activity | 1.25e-03 | 174 | 54 | 4 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 1.34e-03 | 177 | 54 | 4 | GO:0141108 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 1.37e-03 | 81 | 54 | 3 | GO:0035254 | |
| GeneOntologyMolecularFunction | protein phosphatase regulator activity | 2.51e-03 | 100 | 54 | 3 | GO:0019888 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.56e-03 | 891 | 54 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.40e-03 | 229 | 54 | 4 | GO:0003714 | |
| GeneOntologyMolecularFunction | phosphatase regulator activity | 3.55e-03 | 113 | 54 | 3 | GO:0019208 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclic-nucleotide phosphodiesterase activity | 1.70e-08 | 3 | 54 | 3 | GO:0051343 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion export across plasma membrane | 1.69e-07 | 5 | 54 | 3 | GO:1905913 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion export across plasma membrane | 3.37e-07 | 6 | 54 | 3 | GO:1905912 | |
| GeneOntologyBiologicalProcess | regulation of cyclic-nucleotide phosphodiesterase activity | 3.37e-07 | 6 | 54 | 3 | GO:0051342 | |
| GeneOntologyBiologicalProcess | negative regulation of high voltage-gated calcium channel activity | 9.41e-07 | 8 | 54 | 3 | GO:1901842 | |
| GeneOntologyBiologicalProcess | positive regulation of ryanodine-sensitive calcium-release channel activity | 1.41e-06 | 9 | 54 | 3 | GO:0060316 | |
| GeneOntologyBiologicalProcess | negative regulation of ryanodine-sensitive calcium-release channel activity | 2.76e-06 | 11 | 54 | 3 | GO:0060315 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 3.19e-06 | 87 | 54 | 5 | GO:0086001 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 3.67e-06 | 12 | 54 | 3 | GO:1990034 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling involved in cardiac conduction | 3.67e-06 | 12 | 54 | 3 | GO:1901844 | |
| GeneOntologyBiologicalProcess | detection of calcium ion | 4.76e-06 | 13 | 54 | 3 | GO:0005513 | |
| GeneOntologyBiologicalProcess | regulation of high voltage-gated calcium channel activity | 9.27e-06 | 16 | 54 | 3 | GO:1901841 | |
| GeneOntologyBiologicalProcess | negative regulation of release of sequestered calcium ion into cytosol | 1.12e-05 | 17 | 54 | 3 | GO:0051280 | |
| GeneOntologyBiologicalProcess | regulation of cell communication by electrical coupling | 1.35e-05 | 18 | 54 | 3 | GO:0010649 | |
| GeneOntologyBiologicalProcess | action potential | 1.39e-05 | 201 | 54 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | positive regulation of cation channel activity | 1.39e-05 | 56 | 54 | 4 | GO:2001259 | |
| GeneOntologyBiologicalProcess | positive regulation of sequestering of calcium ion | 1.60e-05 | 19 | 54 | 3 | GO:0051284 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 2.14e-05 | 217 | 54 | 6 | GO:0006941 | |
| GeneOntologyBiologicalProcess | negative regulation of voltage-gated calcium channel activity | 2.18e-05 | 21 | 54 | 3 | GO:1901386 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 2.52e-05 | 22 | 54 | 3 | GO:0010881 | |
| GeneOntologyBiologicalProcess | negative regulation of peptidyl-threonine phosphorylation | 3.30e-05 | 24 | 54 | 3 | GO:0010801 | |
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 4.23e-05 | 26 | 54 | 3 | GO:0060314 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling involved in cardiac conduction | 4.23e-05 | 26 | 54 | 3 | GO:0086064 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction by calcium ion signaling | 5.31e-05 | 28 | 54 | 3 | GO:0010882 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 5.91e-05 | 29 | 54 | 3 | GO:0031954 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell action potential | 6.55e-05 | 30 | 54 | 3 | GO:0098901 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphatase activity | 7.24e-05 | 31 | 54 | 3 | GO:0010922 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 7.52e-05 | 167 | 54 | 5 | GO:0060048 | |
| GeneOntologyBiologicalProcess | negative regulation of ion transmembrane transporter activity | 7.95e-05 | 87 | 54 | 4 | GO:0032413 | |
| GeneOntologyBiologicalProcess | positive regulation of peptidyl-threonine phosphorylation | 7.97e-05 | 32 | 54 | 3 | GO:0010800 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 8.75e-05 | 33 | 54 | 3 | GO:0010880 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 9.47e-05 | 91 | 54 | 4 | GO:0140115 | |
| GeneOntologyBiologicalProcess | cell communication by electrical coupling | 1.05e-04 | 35 | 54 | 3 | GO:0010644 | |
| GeneOntologyBiologicalProcess | positive regulation of ion transmembrane transporter activity | 1.21e-04 | 97 | 54 | 4 | GO:0032414 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.24e-04 | 37 | 54 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | regulation of cytokinesis | 1.31e-04 | 99 | 54 | 4 | GO:0032465 | |
| GeneOntologyBiologicalProcess | regulation of voltage-gated calcium channel activity | 1.34e-04 | 38 | 54 | 3 | GO:1901385 | |
| GeneOntologyBiologicalProcess | cardiac conduction | 1.37e-04 | 100 | 54 | 4 | GO:0061337 | |
| GeneOntologyBiologicalProcess | mRNA 3'-splice site recognition | 1.40e-04 | 7 | 54 | 2 | GO:0000389 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transporter activity | 1.45e-04 | 39 | 54 | 3 | GO:1901021 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.45e-04 | 39 | 54 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transporter activity | 1.69e-04 | 41 | 54 | 3 | GO:1901020 | |
| GeneOntologyBiologicalProcess | positive regulation of transporter activity | 1.77e-04 | 107 | 54 | 4 | GO:0032411 | |
| GeneOntologyBiologicalProcess | autophagosome membrane docking | 1.86e-04 | 8 | 54 | 2 | GO:0016240 | |
| GeneOntologyBiologicalProcess | cell junction organization | 1.90e-04 | 974 | 54 | 10 | GO:0034330 | |
| GeneOntologyBiologicalProcess | negative regulation of transporter activity | 1.97e-04 | 110 | 54 | 4 | GO:0032410 | |
| GeneOntologyBiologicalProcess | sarcoplasmic reticulum calcium ion transport | 2.08e-04 | 44 | 54 | 3 | GO:0070296 | |
| GeneOntologyBiologicalProcess | substantia nigra development | 2.23e-04 | 45 | 54 | 3 | GO:0021762 | |
| GeneOntologyBiologicalProcess | regulation of DNA binding | 2.34e-04 | 115 | 54 | 4 | GO:0051101 | |
| GeneOntologyBiologicalProcess | regulation of protein autophosphorylation | 2.38e-04 | 46 | 54 | 3 | GO:0031952 | |
| GeneOntologyBiologicalProcess | mitochondrion-endoplasmic reticulum membrane tethering | 2.39e-04 | 9 | 54 | 2 | GO:1990456 | |
| GeneOntologyBiologicalProcess | negative regulation of cation transmembrane transport | 2.42e-04 | 116 | 54 | 4 | GO:1904063 | |
| GeneOntologyBiologicalProcess | positive regulation of release of sequestered calcium ion into cytosol | 2.70e-04 | 48 | 54 | 3 | GO:0051281 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron differentiation | 3.02e-04 | 123 | 54 | 4 | GO:0045666 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transmembrane transport | 3.12e-04 | 124 | 54 | 4 | GO:0034766 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA binding | 3.42e-04 | 52 | 54 | 3 | GO:0043388 | |
| GeneOntologyBiologicalProcess | regulation of peptidyl-threonine phosphorylation | 3.42e-04 | 52 | 54 | 3 | GO:0010799 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 3.63e-04 | 129 | 54 | 4 | GO:0002027 | |
| GeneOntologyBiologicalProcess | negative regulation of cation channel activity | 4.26e-04 | 56 | 54 | 3 | GO:2001258 | |
| GeneOntologyBiologicalProcess | regulation of cation channel activity | 4.68e-04 | 138 | 54 | 4 | GO:2001257 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 4.97e-04 | 59 | 54 | 3 | GO:0086065 | |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 5.36e-04 | 255 | 54 | 5 | GO:0045664 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 5.42e-04 | 392 | 54 | 6 | GO:0070588 | |
| GeneOntologyBiologicalProcess | positive regulation of dephosphorylation | 5.75e-04 | 62 | 54 | 3 | GO:0035306 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 5.96e-04 | 922 | 54 | 9 | GO:0098662 | |
| GeneOntologyBiologicalProcess | cellular response to electrical stimulus | 6.00e-04 | 14 | 54 | 2 | GO:0071257 | |
| GeneOntologyBiologicalProcess | muscle contraction | 6.03e-04 | 400 | 54 | 6 | GO:0006936 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 6.95e-04 | 942 | 54 | 9 | GO:0098655 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport | 7.87e-04 | 69 | 54 | 3 | GO:1903170 | |
| GeneOntologyBiologicalProcess | neural nucleus development | 8.90e-04 | 72 | 54 | 3 | GO:0048857 | |
| GeneOntologyBiologicalProcess | regulation of phosphatase activity | 9.64e-04 | 74 | 54 | 3 | GO:0010921 | |
| GeneOntologyBiologicalProcess | positive regulation of binding | 1.02e-03 | 170 | 54 | 4 | GO:0051099 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transport | 1.04e-03 | 171 | 54 | 4 | GO:0043271 | |
| GeneOntologyBiologicalProcess | metal ion transport | 1.06e-03 | 1000 | 54 | 9 | GO:0030001 | |
| GeneOntologyBiologicalProcess | heart contraction | 1.08e-03 | 298 | 54 | 5 | GO:0060047 | |
| GeneOntologyBiologicalProcess | positive regulation of cation transmembrane transport | 1.11e-03 | 174 | 54 | 4 | GO:1904064 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane transport | 1.14e-03 | 175 | 54 | 4 | GO:0034763 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.17e-03 | 79 | 54 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 1.19e-03 | 1017 | 54 | 9 | GO:0098660 | |
| GeneOntologyBiologicalProcess | regulation of action potential | 1.25e-03 | 81 | 54 | 3 | GO:0098900 | |
| GeneOntologyBiologicalProcess | heart process | 1.27e-03 | 309 | 54 | 5 | GO:0003015 | |
| GeneOntologyBiologicalProcess | organelle localization by membrane tethering | 1.44e-03 | 85 | 54 | 3 | GO:0140056 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 1.50e-03 | 321 | 54 | 5 | GO:0099003 | |
| GeneOntologyBiologicalProcess | positive regulation of monoatomic ion transmembrane transport | 1.60e-03 | 192 | 54 | 4 | GO:0034767 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 1.64e-03 | 89 | 54 | 3 | GO:0055117 | |
| GeneOntologyBiologicalProcess | membrane docking | 1.75e-03 | 91 | 54 | 3 | GO:0022406 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 1.81e-03 | 92 | 54 | 3 | GO:1901019 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transport | 1.81e-03 | 92 | 54 | 3 | GO:0051926 | |
| GeneOntologyBiologicalProcess | regulation of cell division | 1.89e-03 | 201 | 54 | 4 | GO:0051302 | |
| GeneOntologyBiologicalProcess | synapse organization | 1.97e-03 | 685 | 54 | 7 | GO:0050808 | |
| GeneOntologyBiologicalProcess | cytokinesis | 2.00e-03 | 204 | 54 | 4 | GO:0000910 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 2.08e-03 | 509 | 54 | 6 | GO:0006816 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | 2.08e-03 | 509 | 54 | 6 | GO:0044772 | |
| GeneOntologyBiologicalProcess | establishment of apical/basal cell polarity | 2.10e-03 | 26 | 54 | 2 | GO:0035089 | |
| GeneOntologyBiologicalProcess | midbrain development | 2.10e-03 | 97 | 54 | 3 | GO:0030901 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol | 2.16e-03 | 98 | 54 | 3 | GO:0051279 | |
| GeneOntologyBiologicalProcess | cell division | 2.17e-03 | 697 | 54 | 7 | GO:0051301 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | 2.25e-03 | 1115 | 54 | 9 | GO:0034220 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 2.43e-03 | 102 | 54 | 3 | GO:0140238 | |
| GeneOntologyBiologicalProcess | establishment of monopolar cell polarity | 2.43e-03 | 28 | 54 | 2 | GO:0061162 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.33e-08 | 73 | 54 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | cation channel complex | 1.51e-07 | 235 | 54 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.65e-07 | 253 | 54 | 8 | GO:0030427 | |
| GeneOntologyCellularComponent | growth cone | 3.09e-06 | 245 | 54 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 3.74e-06 | 91 | 54 | 5 | GO:0008076 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 5.34e-06 | 378 | 54 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | potassium channel complex | 7.21e-06 | 104 | 54 | 5 | GO:0034705 | |
| GeneOntologyCellularComponent | spindle pole | 1.44e-05 | 205 | 54 | 6 | GO:0000922 | |
| GeneOntologyCellularComponent | myelin sheath | 1.99e-05 | 217 | 54 | 6 | GO:0043209 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 5.50e-05 | 523 | 54 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 7.83e-05 | 550 | 54 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | calyx of Held | 1.10e-04 | 36 | 54 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | distal axon | 1.23e-04 | 435 | 54 | 7 | GO:0150034 | |
| GeneOntologyCellularComponent | sperm midpiece | 6.07e-04 | 64 | 54 | 3 | GO:0097225 | |
| GeneOntologyCellularComponent | centrosome | 7.59e-04 | 770 | 54 | 8 | GO:0005813 | |
| GeneOntologyCellularComponent | spindle | 1.31e-03 | 471 | 54 | 6 | GO:0005819 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.39e-03 | 85 | 54 | 3 | GO:0000118 | |
| GeneOntologyCellularComponent | spindle microtubule | 1.43e-03 | 86 | 54 | 3 | GO:0005876 | |
| GeneOntologyCellularComponent | axon | 1.93e-03 | 891 | 54 | 8 | GO:0030424 | |
| GeneOntologyCellularComponent | microtubule organizing center | 2.34e-03 | 919 | 54 | 8 | GO:0005815 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 2.68e-03 | 107 | 54 | 3 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 2.68e-03 | 107 | 54 | 3 | GO:0001725 | |
| GeneOntologyCellularComponent | actomyosin | 3.44e-03 | 117 | 54 | 3 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 3.53e-03 | 118 | 54 | 3 | GO:0032432 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.91e-03 | 785 | 54 | 7 | GO:0098797 | |
| GeneOntologyCellularComponent | filopodium | 3.96e-03 | 123 | 54 | 3 | GO:0030175 | |
| GeneOntologyCellularComponent | transcription regulator complex | 4.24e-03 | 596 | 54 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | membrane protein complex | TOMM20L CALM1 CALM2 KCND3 CALM3 PKD1L1 CACHD1 SNAP25 PATJ MICU1 | 4.55e-03 | 1498 | 54 | 10 | GO:0098796 |
| HumanPheno | Polymorphic ventricular tachycardia | 8.23e-06 | 10 | 22 | 3 | HP:0031677 | |
| HumanPheno | Supraventricular arrhythmia | 1.56e-05 | 134 | 22 | 6 | HP:0005115 | |
| HumanPheno | 2:1 atrioventricular block | 1.78e-05 | 2 | 22 | 2 | HP:0034305 | |
| HumanPheno | Second degree atrioventricular block | 3.08e-05 | 15 | 22 | 3 | HP:0011706 | |
| HumanPheno | T-wave alternans | 5.33e-05 | 3 | 22 | 2 | HP:0012266 | |
| HumanPheno | Abnormal cardiac exercise stress test | 6.48e-05 | 19 | 22 | 3 | HP:0500018 | |
| HumanPheno | Prolonged QT interval | 7.16e-05 | 54 | 22 | 4 | HP:0001657 | |
| HumanPheno | Supraventricular tachycardia | 1.27e-04 | 120 | 22 | 5 | HP:0004755 | |
| HumanPheno | Ventricular fibrillation | 1.32e-04 | 63 | 22 | 4 | HP:0001663 | |
| HumanPheno | Abnormal QT interval | 1.40e-04 | 64 | 22 | 4 | HP:0031547 | |
| HumanPheno | Torsade de pointes | 1.51e-04 | 25 | 22 | 3 | HP:0001664 | |
| HumanPheno | Ventricular tachycardia | 1.88e-04 | 69 | 22 | 4 | HP:0004756 | |
| HumanPheno | Abnormal atrioventricular conduction | 1.93e-04 | 131 | 22 | 5 | HP:0005150 | |
| HumanPheno | Atrioventricular nodal disease | 1.93e-04 | 131 | 22 | 5 | HP:0005142 | |
| HumanPheno | Heart block | 2.30e-04 | 136 | 22 | 5 | HP:0012722 | |
| HumanPheno | Prolonged QTc interval | 2.38e-04 | 29 | 22 | 3 | HP:0005184 | |
| HumanPheno | Sinus bradycardia | 2.63e-04 | 30 | 22 | 3 | HP:0001688 | |
| HumanPheno | Abnormal electrophysiology of sinoatrial node origin | 3.49e-04 | 81 | 22 | 4 | HP:0011702 | |
| HumanPheno | Cardiac arrest | 4.76e-04 | 159 | 22 | 5 | HP:0001695 | |
| HumanPheno | Atrial fibrillation | 4.80e-04 | 88 | 22 | 4 | HP:0005110 | |
| HumanPheno | Abnormal T-wave | 4.94e-04 | 37 | 22 | 3 | HP:0005135 | |
| HumanPheno | Atrial arrhythmia | 5.92e-04 | 93 | 22 | 4 | HP:0001692 | |
| HumanPheno | Atrioventricular block | 5.92e-04 | 93 | 22 | 4 | HP:0001678 | |
| HumanPheno | Heart block | 5.92e-04 | 93 | 22 | 4 | HP:0001668 | |
| HumanPheno | Cardiac conduction abnormality | 5.97e-04 | 167 | 22 | 5 | HP:0031546 | |
| Domain | ZnF_U1 | 6.67e-05 | 29 | 51 | 3 | SM00451 | |
| Domain | Znf_U1 | 6.67e-05 | 29 | 51 | 3 | IPR003604 | |
| Domain | EF_Hand_1_Ca_BS | 1.32e-03 | 175 | 51 | 4 | IPR018247 | |
| Domain | EF_HAND_1 | 2.31e-03 | 204 | 51 | 4 | PS00018 | |
| Domain | Chromodomain-like | 3.44e-03 | 32 | 51 | 2 | IPR016197 | |
| Domain | EF_HAND_2 | 3.61e-03 | 231 | 51 | 4 | PS50222 | |
| Domain | Chromo/shadow_dom | 3.66e-03 | 33 | 51 | 2 | IPR000953 | |
| Domain | CHROMO | 3.66e-03 | 33 | 51 | 2 | SM00298 | |
| Domain | EF_hand_dom | 3.67e-03 | 232 | 51 | 4 | IPR002048 | |
| Domain | ZF_CCHC | 4.11e-03 | 35 | 51 | 2 | PS50158 | |
| Domain | EF-hand-dom_pair | 7.74e-03 | 287 | 51 | 4 | IPR011992 | |
| Pathway | REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB | 2.63e-07 | 5 | 43 | 3 | MM14493 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS | 5.25e-07 | 6 | 43 | 3 | MM15662 | |
| Pathway | REACTOME_CAM_PDE_1_ACTIVATION | 5.25e-07 | 6 | 43 | 3 | MM14494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 6.37e-07 | 23 | 43 | 4 | MM15222 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 9.17e-07 | 7 | 43 | 3 | MM1357 | |
| Pathway | BIOCARTA_CACAM_PATHWAY | 2.19e-06 | 9 | 43 | 3 | M3412 | |
| Pathway | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | 3.13e-06 | 10 | 43 | 3 | MM14570 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE | 3.13e-06 | 10 | 43 | 3 | M47954 | |
| Pathway | REACTOME_CALCINEURIN_ACTIVATES_NFAT | 4.29e-06 | 11 | 43 | 3 | MM14810 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 4.29e-06 | 11 | 43 | 3 | M47958 | |
| Pathway | REACTOME_ENOS_ACTIVATION | 5.71e-06 | 12 | 43 | 3 | MM14817 | |
| Pathway | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | 5.71e-06 | 12 | 43 | 3 | MM15142 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY | 5.71e-06 | 12 | 43 | 3 | M47956 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 7.40e-06 | 13 | 43 | 3 | MM15078 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 9.40e-06 | 14 | 43 | 3 | MM1473 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 9.40e-06 | 14 | 43 | 3 | M47386 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY | 9.40e-06 | 14 | 43 | 3 | M47388 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 9.40e-06 | 14 | 43 | 3 | MM15391 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 9.40e-06 | 14 | 43 | 3 | MM15052 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.17e-05 | 15 | 43 | 3 | M47385 | |
| Pathway | BIOCARTA_PGC1A_PATHWAY | 1.17e-05 | 15 | 43 | 3 | M15181 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 1.17e-05 | 15 | 43 | 3 | MM15103 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.17e-05 | 15 | 43 | 3 | MM1387 | |
| Pathway | REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION | 1.17e-05 | 15 | 43 | 3 | MM14795 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.20e-05 | 99 | 43 | 5 | MM14910 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 1.44e-05 | 16 | 43 | 3 | MM1483 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 1.44e-05 | 16 | 43 | 3 | M47449 | |
| Pathway | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | 1.44e-05 | 16 | 43 | 3 | MM14492 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 1.74e-05 | 17 | 43 | 3 | M2349 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.74e-05 | 17 | 43 | 3 | M10066 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY | 1.74e-05 | 17 | 43 | 3 | M47387 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 1.74e-05 | 17 | 43 | 3 | M47560 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.74e-05 | 17 | 43 | 3 | M5940 | |
| Pathway | BIOCARTA_GCR_PATHWAY | 1.74e-05 | 17 | 43 | 3 | MM1372 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 2.09e-05 | 18 | 43 | 3 | M3430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 2.09e-05 | 18 | 43 | 3 | M47580 | |
| Pathway | BIOCARTA_MEF2D_PATHWAY | 2.09e-05 | 18 | 43 | 3 | M5290 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 2.09e-05 | 18 | 43 | 3 | MM15577 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 2.09e-05 | 18 | 43 | 3 | MM1385 | |
| Pathway | BIOCARTA_CCR5_PATHWAY | 2.48e-05 | 19 | 43 | 3 | MM1453 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 2.48e-05 | 19 | 43 | 3 | M47543 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY | 2.48e-05 | 19 | 43 | 3 | M47957 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 2.91e-05 | 20 | 43 | 3 | MM1445 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY | 3.38e-05 | 21 | 43 | 3 | M47542 | |
| Pathway | BIOCARTA_NOS1_PATHWAY | 3.38e-05 | 21 | 43 | 3 | M11650 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 3.91e-05 | 22 | 43 | 3 | MM15104 | |
| Pathway | REACTOME_PROTEIN_METHYLATION | 3.91e-05 | 22 | 43 | 3 | MM15519 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 4.49e-05 | 23 | 43 | 3 | M47512 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.12e-05 | 24 | 43 | 3 | M47509 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 5.80e-05 | 25 | 43 | 3 | MM1441 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.80e-05 | 25 | 43 | 3 | M47510 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 5.80e-05 | 25 | 43 | 3 | M47511 | |
| Pathway | REACTOME_METABOLISM_OF_COFACTORS | 5.80e-05 | 25 | 43 | 3 | MM15574 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 5.80e-05 | 25 | 43 | 3 | M1547 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 6.55e-05 | 26 | 43 | 3 | MM1346 | |
| Pathway | BIOCARTA_VIP_PATHWAY | 6.55e-05 | 26 | 43 | 3 | M17941 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 6.55e-05 | 26 | 43 | 3 | MM1431 | |
| Pathway | REACTOME_CA_DEPENDENT_EVENTS | 6.55e-05 | 26 | 43 | 3 | MM14495 | |
| Pathway | BIOCARTA_HDAC_PATHWAY | 6.55e-05 | 26 | 43 | 3 | MM1371 | |
| Pathway | BIOCARTA_AT1R_PATHWAY | 7.35e-05 | 27 | 43 | 3 | M14899 | |
| Pathway | BIOCARTA_PYK2_PATHWAY | 7.35e-05 | 27 | 43 | 3 | M7739 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 7.35e-05 | 27 | 43 | 3 | MM15053 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 8.21e-05 | 28 | 43 | 3 | MM14711 | |
| Pathway | BIOCARTA_NO1_PATHWAY | 8.21e-05 | 28 | 43 | 3 | M4383 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 8.21e-05 | 28 | 43 | 3 | M47508 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 9.14e-05 | 29 | 43 | 3 | MM1356 | |
| Pathway | BIOCARTA_BIOPEPTIDES_PATHWAY | 9.14e-05 | 29 | 43 | 3 | M13494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 9.14e-05 | 29 | 43 | 3 | MM15219 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 9.14e-05 | 29 | 43 | 3 | MM1495 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY | 1.01e-04 | 30 | 43 | 3 | MM15170 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 1.01e-04 | 30 | 43 | 3 | M9664 | |
| Pathway | REACTOME_THE_PHOTOTRANSDUCTION_CASCADE | 1.12e-04 | 31 | 43 | 3 | MM14896 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 1.23e-04 | 32 | 43 | 3 | MM1355 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 1.23e-04 | 32 | 43 | 3 | MM15143 | |
| Pathway | BIOCARTA_BCR_PATHWAY | 1.35e-04 | 33 | 43 | 3 | M9494 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 1.48e-04 | 34 | 43 | 3 | M10287 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 1.48e-04 | 34 | 43 | 3 | MM15985 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 1.48e-04 | 34 | 43 | 3 | MM1399 | |
| Pathway | REACTOME_RAF_ACTIVATION | 1.62e-04 | 35 | 43 | 3 | MM15271 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.62e-04 | 35 | 43 | 3 | MM15109 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 1.62e-04 | 35 | 43 | 3 | MM15114 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.88e-04 | 176 | 43 | 5 | MM15718 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 2.24e-04 | 39 | 43 | 3 | M1908 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 2.24e-04 | 39 | 43 | 3 | MM14496 | |
| Pathway | BIOCARTA_FCER1_PATHWAY | 2.24e-04 | 39 | 43 | 3 | MM1397 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 2.41e-04 | 40 | 43 | 3 | M39595 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.66e-04 | 103 | 43 | 4 | MM15196 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 2.79e-04 | 42 | 43 | 3 | MM1504 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 3.21e-04 | 44 | 43 | 3 | M39845 | |
| Pathway | BIOCARTA_TCR_PATHWAY | 3.21e-04 | 44 | 43 | 3 | M19784 | |
| Pathway | REACTOME_CA2_PATHWAY | 3.43e-04 | 45 | 43 | 3 | MM15040 | |
| Pathway | REACTOME_RAS_PROCESSING | 3.43e-04 | 45 | 43 | 3 | MM15671 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 4.16e-04 | 48 | 43 | 3 | MM14589 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 4.42e-04 | 49 | 43 | 3 | MM1442 | |
| Pathway | BIOCARTA_NFAT_PATHWAY | 4.97e-04 | 51 | 43 | 3 | M2288 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.88e-04 | 54 | 43 | 3 | MM15202 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 6.21e-04 | 55 | 43 | 3 | MM14932 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | HDAC9 NEDD4L CALM1 USP9X ANAPC15 SLU7 ZFHX3 CHD4 SNAPC1 REST ZNF710 IWS1 | 6.66e-04 | 1387 | 43 | 12 | M734 |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 6.90e-04 | 57 | 43 | 3 | MM15643 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 7.26e-04 | 58 | 43 | 3 | MM14914 | |
| Pubmed | HDAC9 FRY MIA2 CALM1 STAG1 MYH14 USP9X NASP NBEA SPARCL1 CHD4 CACHD1 SNAP25 VCPIP1 MICU1 | 6.73e-10 | 1285 | 54 | 15 | 35914814 | |
| Pubmed | 1.70e-09 | 11 | 54 | 4 | 10757985 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 29932249 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 18370588 | ||
| Pubmed | Structural organization of the human CaMIII calmodulin gene. | 3.54e-09 | 3 | 54 | 3 | 2223880 | |
| Pubmed | Molecular mechanisms of calmodulin's functional versatility. | 3.54e-09 | 3 | 54 | 3 | 9923700 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 9681195 | ||
| Pubmed | Allosteric mechanism of water-channel gating by Ca2+-calmodulin. | 3.54e-09 | 3 | 54 | 3 | 23893133 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 18940602 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 25268113 | ||
| Pubmed | Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. | 3.54e-09 | 3 | 54 | 3 | 8573130 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 19651602 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 10899953 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 26969752 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 8314583 | ||
| Pubmed | Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. | 3.54e-09 | 3 | 54 | 3 | 11807546 | |
| Pubmed | Fluorescent indicators for Ca2+ based on green fluorescent proteins and calmodulin. | 3.54e-09 | 3 | 54 | 3 | 9278050 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 15719022 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 8312049 | ||
| Pubmed | Nef of HIV-1 interacts directly with calcium-bound calmodulin. | 3.54e-09 | 3 | 54 | 3 | 11847276 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 10416864 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 7828884 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 8862395 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 37380439 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 31628181 | ||
| Pubmed | Sequence homology of the 3'-untranslated region of calmodulin III in mammals. | 3.54e-09 | 3 | 54 | 3 | 11710561 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 2445749 | ||
| Pubmed | Signal peptide fragments of preprolactin and HIV-1 p-gp160 interact with calmodulin. | 3.54e-09 | 3 | 54 | 3 | 9362478 | |
| Pubmed | The abundance of calmodulin mRNAs is regulated in phosphorylase kinase-deficient skeletal muscle. | 3.54e-09 | 3 | 54 | 3 | 3384819 | |
| Pubmed | Calmodulin is required for cell-cycle progression during G1 and mitosis. | 3.54e-09 | 3 | 54 | 3 | 2469574 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 21799007 | ||
| Pubmed | Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. | 3.54e-09 | 3 | 54 | 3 | 15632291 | |
| Pubmed | Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. | 3.54e-09 | 3 | 54 | 3 | 20956522 | |
| Pubmed | Noncanonical binding of calmodulin to aquaporin-0: implications for channel regulation. | 3.54e-09 | 3 | 54 | 3 | 18786401 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 11072229 | ||
| Pubmed | Blocking the Ca2+-induced conformational transitions in calmodulin with disulfide bonds. | 3.54e-09 | 3 | 54 | 3 | 8631777 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 18553937 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 16229872 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 14978283 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 15063758 | ||
| Pubmed | Calmodulin and HIV type 1: interactions with Gag and Gag products. | 3.54e-09 | 3 | 54 | 3 | 11054265 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 33191766 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 8226798 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 9658102 | ||
| Pubmed | The ankyrin repeats of TRPV1 bind multiple ligands and modulate channel sensitivity. | 3.54e-09 | 3 | 54 | 3 | 17582331 | |
| Pubmed | Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells. | 1.41e-08 | 4 | 54 | 3 | 14960328 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 22405011 | ||
| Pubmed | A calmodulin-binding sequence in the C-terminus of human cardiac titin kinase. | 1.41e-08 | 4 | 54 | 3 | 7607248 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 27516456 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 11736632 | ||
| Pubmed | Activation mechanism of a human SK-calmodulin channel complex elucidated by cryo-EM structures. | 1.41e-08 | 4 | 54 | 3 | 29724949 | |
| Pubmed | A calcium sensor in the sodium channel modulates cardiac excitability. | 1.41e-08 | 4 | 54 | 3 | 11807557 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 11286509 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 20953164 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 30842726 | ||
| Pubmed | Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death. | 1.41e-08 | 4 | 54 | 3 | 23040497 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 19855925 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 16299511 | ||
| Pubmed | Calmodulin binding to the Fas death domain. Regulation by Fas activation. | 1.41e-08 | 4 | 54 | 3 | 14594800 | |
| Pubmed | Structure of calmodulin bound to the hydrophobic IQ domain of the cardiac Ca(v)1.2 calcium channel. | 1.41e-08 | 4 | 54 | 3 | 16338416 | |
| Pubmed | Role of calmodulin in HIV-potentiated Fas-mediated apoptosis. | 1.41e-08 | 4 | 54 | 3 | 8780394 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 19279214 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 25437912 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 17046994 | ||
| Pubmed | A network of control mediated by regulator of calcium/calmodulin-dependent signaling. | 1.41e-08 | 4 | 54 | 3 | 15499021 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 10692436 | ||
| Pubmed | Requirement of calmodulin binding by HIV-1 gp160 for enhanced FAS-mediated apoptosis. | 1.41e-08 | 4 | 54 | 3 | 10625668 | |
| Pubmed | Molecular basis of the death-associated protein kinase-calcium/calmodulin regulator complex. | 1.41e-08 | 4 | 54 | 3 | 20103772 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 16478480 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 21167176 | ||
| Pubmed | Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. | 1.41e-08 | 4 | 54 | 3 | 16127172 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 9096366 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 12577052 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 20226167 | ||
| Pubmed | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | 1.41e-08 | 4 | 54 | 3 | 22067155 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 25441029 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 10823944 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 16505387 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 26164367 | ||
| Pubmed | Calm1 signaling pathway is essential for the migration of mouse precerebellar neurons. | 1.41e-08 | 4 | 54 | 3 | 25519244 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 27165696 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 15140941 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 11981030 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 12034722 | ||
| Pubmed | Rab3B in human platelet is membrane bound and interacts with Ca(2+)/calmodulin. | 3.53e-08 | 5 | 54 | 3 | 11741295 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 32522888 | ||
| Pubmed | Inhibition of human ether à go-go potassium channels by Ca(2+)/calmodulin. | 3.53e-08 | 5 | 54 | 3 | 10880439 | |
| Pubmed | Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. | 3.53e-08 | 5 | 54 | 3 | 19632986 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 3111527 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 17719545 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 25703379 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 35568036 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 18570893 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 9242710 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 25232683 | ||
| Pubmed | Current inhibition of human EAG1 potassium channels by the Ca2+ binding protein S100B. | 3.53e-08 | 5 | 54 | 3 | 20708613 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 22705208 | ||
| Pubmed | Pathogenic NPHP5 mutations impair protein interaction with Cep290, a prerequisite for ciliogenesis. | 3.53e-08 | 5 | 54 | 3 | 23446637 | |
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 21436055 | ||
| Pubmed | Non-equivalence of embryonic and somatic cell nuclei affecting spindle composition in clones. | 7.05e-08 | 6 | 54 | 3 | 16310175 | |
| Interaction | LRCH3 interactions | 4.31e-07 | 108 | 54 | 6 | int:LRCH3 | |
| Interaction | SPATA17 interactions | 6.32e-07 | 7 | 54 | 3 | int:SPATA17 | |
| Interaction | HDAC1 interactions | HDAC9 ARID4B STAG1 MYH14 SF3A1 GON4L ZFHX3 CHD4 REST NUDCD1 FSCN1 RBM20 VCPIP1 DNMT3B | 8.71e-07 | 1108 | 54 | 14 | int:HDAC1 |
| Interaction | KCNN1 interactions | 1.01e-06 | 8 | 54 | 3 | int:KCNN1 | |
| Interaction | ARPP21 interactions | 1.01e-06 | 8 | 54 | 3 | int:ARPP21 | |
| Interaction | IQCG interactions | 2.15e-06 | 10 | 54 | 3 | int:IQCG | |
| Interaction | C11orf65 interactions | 5.10e-06 | 13 | 54 | 3 | int:C11orf65 | |
| Interaction | POC5 interactions | 5.51e-06 | 95 | 54 | 5 | int:POC5 | |
| Interaction | CAMK2B interactions | 9.00e-06 | 182 | 54 | 6 | int:CAMK2B | |
| Interaction | ZNF280A interactions | 9.94e-06 | 16 | 54 | 3 | int:ZNF280A | |
| Interaction | UNC13B interactions | 1.13e-05 | 52 | 54 | 4 | int:UNC13B | |
| Interaction | CAMTA2 interactions | 1.44e-05 | 18 | 54 | 3 | int:CAMTA2 | |
| Interaction | SCN2A interactions | 1.71e-05 | 19 | 54 | 3 | int:SCN2A | |
| Interaction | PHKB interactions | 2.44e-05 | 63 | 54 | 4 | int:PHKB | |
| Interaction | OGG1 interactions | 3.10e-05 | 23 | 54 | 3 | int:OGG1 | |
| Interaction | NEAT1 interactions | 3.54e-05 | 24 | 54 | 3 | int:NEAT1 | |
| Interaction | LRRK2 interactions | 4.90e-05 | 496 | 54 | 8 | int:LRRK2 | |
| Interaction | CCDC8 interactions | 5.57e-05 | 656 | 54 | 9 | int:CCDC8 | |
| Interaction | MYL6 interactions | 6.01e-05 | 255 | 54 | 6 | int:MYL6 | |
| Interaction | HTATSF1 interactions | 6.26e-05 | 157 | 54 | 5 | int:HTATSF1 | |
| Interaction | PPEF2 interactions | 6.32e-05 | 29 | 54 | 3 | int:PPEF2 | |
| Interaction | ESCO1 interactions | 7.01e-05 | 30 | 54 | 3 | int:ESCO1 | |
| Interaction | CDC73 interactions | 7.31e-05 | 386 | 54 | 7 | int:CDC73 | |
| Interaction | KCNQ2 interactions | 7.58e-05 | 84 | 54 | 4 | int:KCNQ2 | |
| Interaction | NEUROD1 interactions | 8.54e-05 | 32 | 54 | 3 | int:NEUROD1 | |
| Interaction | SH2B1 interactions | 8.54e-05 | 32 | 54 | 3 | int:SH2B1 | |
| Interaction | DENND4A interactions | 9.92e-05 | 90 | 54 | 4 | int:DENND4A | |
| Interaction | NSMF interactions | 1.12e-04 | 35 | 54 | 3 | int:NSMF | |
| Interaction | CEP290 interactions | 1.16e-04 | 179 | 54 | 5 | int:CEP290 | |
| Interaction | PPP3CA interactions | 1.16e-04 | 179 | 54 | 5 | int:PPP3CA | |
| Interaction | YAP1 interactions | LIMA1 NEDD4L CALM1 CALM3 MYH14 USP9X SF3A1 NASP CHD4 PATJ VCPIP1 | 1.28e-04 | 1095 | 54 | 11 | int:YAP1 |
| Interaction | IQCE interactions | 1.32e-04 | 37 | 54 | 3 | int:IQCE | |
| Interaction | HDAC4 interactions | 1.45e-04 | 744 | 54 | 9 | int:HDAC4 | |
| Interaction | ABHD10 interactions | 1.55e-04 | 101 | 54 | 4 | int:ABHD10 | |
| Interaction | CAMK1 interactions | 1.67e-04 | 103 | 54 | 4 | int:CAMK1 | |
| Interaction | FOXL1 interactions | 1.78e-04 | 196 | 54 | 5 | int:FOXL1 | |
| Interaction | MYL6B interactions | 2.01e-04 | 108 | 54 | 4 | int:MYL6B | |
| Interaction | PHKA1 interactions | 2.08e-04 | 43 | 54 | 3 | int:PHKA1 | |
| Interaction | KCNB1 interactions | 2.08e-04 | 43 | 54 | 3 | int:KCNB1 | |
| Interaction | IQSEC2 interactions | 2.23e-04 | 44 | 54 | 3 | int:IQSEC2 | |
| Interaction | UBE3B interactions | 2.71e-04 | 47 | 54 | 3 | int:UBE3B | |
| Interaction | SCN5A interactions | 2.71e-04 | 47 | 54 | 3 | int:SCN5A | |
| Interaction | CAMKK1 interactions | 2.89e-04 | 48 | 54 | 3 | int:CAMKK1 | |
| Interaction | RCAN1 interactions | 3.66e-04 | 52 | 54 | 3 | int:RCAN1 | |
| Interaction | PPEF1 interactions | 3.66e-04 | 52 | 54 | 3 | int:PPEF1 | |
| Interaction | RBBP7 interactions | 3.90e-04 | 507 | 54 | 7 | int:RBBP7 | |
| Interaction | RBM26 interactions | 4.07e-04 | 130 | 54 | 4 | int:RBM26 | |
| Interaction | CAMK1D interactions | 4.09e-04 | 54 | 54 | 3 | int:CAMK1D | |
| Interaction | SP1 interactions | 4.20e-04 | 365 | 54 | 6 | int:SP1 | |
| Interaction | ANKS6 interactions | 4.56e-04 | 56 | 54 | 3 | int:ANKS6 | |
| Interaction | CABP4 interactions | 4.57e-04 | 12 | 54 | 2 | int:CABP4 | |
| Interaction | TIGD1 interactions | 4.57e-04 | 12 | 54 | 2 | int:TIGD1 | |
| Interaction | RALA interactions | 4.83e-04 | 136 | 54 | 4 | int:RALA | |
| Interaction | SIN3A interactions | 5.20e-04 | 380 | 54 | 6 | int:SIN3A | |
| Interaction | DENND4C interactions | 5.39e-04 | 140 | 54 | 4 | int:DENND4C | |
| Interaction | ASCL2 interactions | 5.39e-04 | 13 | 54 | 2 | int:ASCL2 | |
| Interaction | MOV10 interactions | LIMA1 POLR1A NEDD4L CALM1 CALM3 SF3A1 TUT7 SLU7 FBXO30 VCPIP1 IWS1 | 5.53e-04 | 1297 | 54 | 11 | int:MOV10 |
| Interaction | MYO10 interactions | 5.54e-04 | 141 | 54 | 4 | int:MYO10 | |
| Interaction | GSC2 interactions | 6.15e-04 | 62 | 54 | 3 | int:GSC2 | |
| GeneFamily | EF-hand domain containing | 1.12e-03 | 219 | 38 | 4 | 863 | |
| Coexpression | GUO_HEX_TARGETS_UP | 6.56e-07 | 80 | 54 | 5 | MM626 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 4.85e-06 | 467 | 54 | 8 | M1347 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP | 5.51e-06 | 17 | 54 | 3 | MM686 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 6.30e-06 | 484 | 54 | 8 | MM999 | |
| Coexpression | RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP | 1.42e-05 | 23 | 54 | 3 | MM694 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 2.88e-05 | 85 | 54 | 4 | MM684 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | 4.33e-05 | 312 | 54 | 6 | M39161 | |
| Coexpression | BRUINS_UVC_RESPONSE_EARLY_LATE | 4.98e-05 | 320 | 54 | 6 | MM1063 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 5.56e-05 | 656 | 54 | 8 | M18979 | |
| Coexpression | LEE_AGING_MUSCLE_DN | 1.18e-04 | 46 | 54 | 3 | MM670 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 1.21e-04 | 734 | 54 | 8 | M3835 | |
| Coexpression | JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN | 1.34e-04 | 48 | 54 | 3 | MM529 | |
| Coexpression | TABULA_MURIS_SENIS_BROWN_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 1.35e-04 | 240 | 54 | 5 | MM3678 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_8WK | 1.60e-04 | 51 | 54 | 3 | MM647 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 1.84e-04 | 137 | 54 | 4 | MM990 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.31e-05 | 339 | 54 | 7 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | BM Top 100 - cerebellum | 2.70e-05 | 68 | 54 | 4 | BM Top 100 - cerebellum | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | HDAC9 SEMA3D ARID4B USP9X ZFHX3 NBEA RBM20 FBXO30 VCPIP1 IWS1 | 4.21e-05 | 836 | 54 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 4.75e-05 | 156 | 54 | 5 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | LIMA1 MIA2 ARID4B NEDD4L MYH14 USP9X NASP ZFHX3 CHD4 NUDCD1 CDC14A FBXO30 | 5.71e-05 | 1252 | 54 | 12 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500 | 7.24e-05 | 406 | 54 | 7 | gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 7.47e-05 | 408 | 54 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_500 | 7.77e-05 | 89 | 54 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 8.56e-05 | 417 | 54 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | 1.26e-04 | 769 | 54 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 1.79e-04 | 806 | 54 | 9 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 1.95e-04 | 815 | 54 | 9 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.37e-04 | 492 | 54 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#2_top-relative-expression-ranked_200 | 2.82e-04 | 10 | 54 | 2 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_200_k2 | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.07e-06 | 150 | 54 | 5 | 6a13e4c4b9c9e54a5016573a37132465ec1c8f99 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.09e-06 | 172 | 54 | 5 | adc09c4d1b63fe84150516beb692db1e7f7ac980 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 175 | 54 | 5 | 65571d775d26a40e979dbf290a8e4320c0d9fb3f | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 189 | 54 | 5 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.41e-06 | 190 | 54 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 3.49e-06 | 191 | 54 | 5 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CFuPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.59e-06 | 192 | 54 | 5 | a8841ebd879f1c344ab4246fdef77044170f644d | |
| ToppCell | facs-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-06 | 193 | 54 | 5 | 15c86e20b97b6983410b36d308cddff56d141c98 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.87e-06 | 195 | 54 | 5 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.27e-06 | 199 | 54 | 5 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.37e-06 | 200 | 54 | 5 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Interneuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.37e-06 | 200 | 54 | 5 | 274871d632bbbe03720726a59ab3ec6d5fa0da11 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 162 | 54 | 4 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 162 | 54 | 4 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 162 | 54 | 4 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.78e-05 | 165 | 54 | 4 | e381bcd558745f3a60346f78b49d0b2672184baa | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.13e-05 | 168 | 54 | 4 | 217770a94ace446cdfc7687b459dece707576e76 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.25e-05 | 169 | 54 | 4 | 2abdd8ae9a5d88aac30992142d1b502c959bc015 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.25e-05 | 169 | 54 | 4 | ccb7b2daa65cb5f4c1e7a48b3bcdf0cb8f7675c3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.37e-05 | 170 | 54 | 4 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 170 | 54 | 4 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 170 | 54 | 4 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-05 | 170 | 54 | 4 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.49e-05 | 171 | 54 | 4 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.75e-05 | 173 | 54 | 4 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-05 | 173 | 54 | 4 | 73f858f2c45d19b9ec8d99ac02c91551790f670c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-05 | 173 | 54 | 4 | 37457ce2b0bb2a56d6e56f6fd9c668eb40c70ae0 | |
| ToppCell | Thalamus-Neuronal-Excitatory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.14e-05 | 176 | 54 | 4 | d2bbf13d21fb7582d7e5f90cd61a4ebe1cfccd66 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 176 | 54 | 4 | ed421d8525108d2f585265d2cf777f07b29f44f0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.14e-05 | 176 | 54 | 4 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.42e-05 | 178 | 54 | 4 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.56e-05 | 179 | 54 | 4 | 8ce5000088b727783a0619baa16a2cd036d21f54 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 180 | 54 | 4 | d76349ecef7c5878bf215e946f032264161eb61b | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.70e-05 | 180 | 54 | 4 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 180 | 54 | 4 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 180 | 54 | 4 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 6.85e-05 | 181 | 54 | 4 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 7.15e-05 | 183 | 54 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.15e-05 | 183 | 54 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 184 | 54 | 4 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 7.45e-05 | 185 | 54 | 4 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 185 | 54 | 4 | cdd75abdaa1ecedfd2e636203b83a6ac1782f0c3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 185 | 54 | 4 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 7.45e-05 | 185 | 54 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 7.45e-05 | 185 | 54 | 4 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 185 | 54 | 4 | c083a4974590b9ed3ecafedd3e9cdebc5047fe39 | |
| ToppCell | 18-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 7.45e-05 | 185 | 54 | 4 | f8fc7b12b4e18d23d84e95488be93c4352d325f3 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.45e-05 | 185 | 54 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-05 | 186 | 54 | 4 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 7.61e-05 | 186 | 54 | 4 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 54 | 4 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 7.77e-05 | 187 | 54 | 4 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 54 | 4 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | 15-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 7.77e-05 | 187 | 54 | 4 | a7d2f30fe0f19e63d44603ece9890acd11b45e52 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 7.93e-05 | 188 | 54 | 4 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 7.93e-05 | 188 | 54 | 4 | 0758b474457efa36488e0195f7357100f4b6a090 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.93e-05 | 188 | 54 | 4 | 63773854bf8430fb8229edb385b953a89833d08c | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 7.93e-05 | 188 | 54 | 4 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.10e-05 | 189 | 54 | 4 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 8.10e-05 | 189 | 54 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | 18-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 8.10e-05 | 189 | 54 | 4 | 144beb01b908f2cd0e04513fb84d817e0c3c124e | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 8.10e-05 | 189 | 54 | 4 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 189 | 54 | 4 | f57200c93d39c9bce1adba0a6a1c178c028dd86b | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 8.26e-05 | 190 | 54 | 4 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 8.26e-05 | 190 | 54 | 4 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.26e-05 | 190 | 54 | 4 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 8.26e-05 | 190 | 54 | 4 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | facs-Pancreas-Endocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-05 | 191 | 54 | 4 | b3de0393d6510543533cd851e47a0f95739a0e4e | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.43e-05 | 191 | 54 | 4 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 8.43e-05 | 191 | 54 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 8.43e-05 | 191 | 54 | 4 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.43e-05 | 191 | 54 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-05 | 191 | 54 | 4 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.43e-05 | 191 | 54 | 4 | 657297cd19d05a7e7bb74fc3a086fbd95f47aae4 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 8.60e-05 | 192 | 54 | 4 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.60e-05 | 192 | 54 | 4 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.60e-05 | 192 | 54 | 4 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 8.60e-05 | 192 | 54 | 4 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 8.60e-05 | 192 | 54 | 4 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.60e-05 | 192 | 54 | 4 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 192 | 54 | 4 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.60e-05 | 192 | 54 | 4 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 8.60e-05 | 192 | 54 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 192 | 54 | 4 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | Epithelial-club_cell|World / Lineage, Cell type, age group and donor | 8.78e-05 | 193 | 54 | 4 | 2bdd09004fa433550958ec42ba4b06271a4aaf7c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-05 | 193 | 54 | 4 | 5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 8.95e-05 | 194 | 54 | 4 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.95e-05 | 194 | 54 | 4 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 8.95e-05 | 194 | 54 | 4 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.95e-05 | 194 | 54 | 4 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | LAM-Endothelial|LAM / Condition, Lineage and Cell class | 8.95e-05 | 194 | 54 | 4 | 1241e3e75414b619abc9431627619f5c194ec930 | |
| ToppCell | Primary_Visual_cortex_(V1C)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.13e-05 | 195 | 54 | 4 | 24dbb125565facd2de42d848471d4867c81acf80 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 195 | 54 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.13e-05 | 195 | 54 | 4 | fca958f73de450ef813444d3dc590353f1c55326 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 9.13e-05 | 195 | 54 | 4 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| Drug | NSC366363 | 1.26e-08 | 3 | 54 | 3 | CID000339501 | |
| Drug | AC1NDS53 | 1.26e-08 | 3 | 54 | 3 | CID004630710 | |
| Drug | tatsiensine | 1.26e-08 | 3 | 54 | 3 | CID000163526 | |
| Drug | delcosine | 1.26e-08 | 3 | 54 | 3 | CID000120726 | |
| Drug | NSC-114340 | 5.03e-08 | 16 | 54 | 4 | CID000004598 | |
| Drug | thiomethylpromazine | 5.04e-08 | 4 | 54 | 3 | CID000070583 | |
| Drug | KS-504e | 5.04e-08 | 4 | 54 | 3 | CID000129559 | |
| Drug | KS-504d | 5.04e-08 | 4 | 54 | 3 | CID000129557 | |
| Drug | Archanagelicine | 5.04e-08 | 4 | 54 | 3 | CID003083773 | |
| Drug | Nsc642900 | 5.04e-08 | 4 | 54 | 3 | CID000498959 | |
| Drug | CTK0F9956 | 5.04e-08 | 4 | 54 | 3 | CID011779542 | |
| Drug | N,N-dimethyladriamycin-14-valerate | 5.04e-08 | 4 | 54 | 3 | CID000127194 | |
| Drug | 85318-25-8 | 5.04e-08 | 4 | 54 | 3 | CID006439702 | |
| Drug | cloxacepride | 5.04e-08 | 4 | 54 | 3 | CID000068859 | |
| Drug | Roylin | 5.04e-08 | 4 | 54 | 3 | CID000099924 | |
| Drug | chloraniformethan | 5.04e-08 | 4 | 54 | 3 | CID000030331 | |
| Drug | KS-502 | 5.04e-08 | 4 | 54 | 3 | CID000129242 | |
| Drug | KS-501 | 5.04e-08 | 4 | 54 | 3 | CID000129240 | |
| Drug | 2'-methoxykobusin | 5.04e-08 | 4 | 54 | 3 | CID000637889 | |
| Drug | Ti 233 | 5.04e-08 | 4 | 54 | 3 | CID000173248 | |
| Drug | diisopropylphosphoramidite | 5.04e-08 | 4 | 54 | 3 | CID000080867 | |
| Drug | PS-990 | 5.04e-08 | 4 | 54 | 3 | CID000157810 | |
| Drug | herbarumin III | 5.04e-08 | 4 | 54 | 3 | CID000643678 | |
| Drug | jujubogenin | 1.26e-07 | 5 | 54 | 3 | CID005318721 | |
| Drug | D 890 | 1.26e-07 | 5 | 54 | 3 | CID000134083 | |
| Drug | 4H-1,4-benzothiazin-3-one | 1.26e-07 | 5 | 54 | 3 | CID000021396 | |
| Drug | Y-acid | 1.26e-07 | 5 | 54 | 3 | CID000007022 | |
| Drug | NSC-36360 | 1.26e-07 | 5 | 54 | 3 | CID000133340 | |
| Drug | C16AA | 1.26e-07 | 5 | 54 | 3 | CID000488017 | |
| Drug | auranthine | 1.26e-07 | 5 | 54 | 3 | CID000130919 | |
| Drug | alpha-CAO | 1.26e-07 | 5 | 54 | 3 | CID000196600 | |
| Drug | AC1NS8P3 | 1.26e-07 | 5 | 54 | 3 | CID005356151 | |
| Drug | Ant-ATP | 1.26e-07 | 5 | 54 | 3 | CID000134953 | |
| Drug | Nor2 chlorpromazine | 1.26e-07 | 5 | 54 | 3 | CID000074981 | |
| Drug | Fsh-beta-(1-15) | 1.26e-07 | 5 | 54 | 3 | CID005748474 | |
| Drug | Ac-dvda | 1.26e-07 | 5 | 54 | 3 | CID000146768 | |
| Drug | VUF 4576 | 1.26e-07 | 5 | 54 | 3 | CID000132784 | |
| Drug | mdDA | 2.00e-07 | 22 | 54 | 4 | CID000451450 | |
| Drug | 2,5-diketocamphane | 2.51e-07 | 6 | 54 | 3 | CID000020218 | |
| Drug | AC1NSV6X | 2.51e-07 | 6 | 54 | 3 | CID005317173 | |
| Drug | benziodarone | 2.51e-07 | 6 | 54 | 3 | CID000006237 | |
| Drug | AC1LCMSV | 2.51e-07 | 6 | 54 | 3 | CID000633347 | |
| Drug | CI-922 | 2.51e-07 | 6 | 54 | 3 | CID000146938 | |
| Drug | caged PE | 2.51e-07 | 6 | 54 | 3 | CID000192405 | |
| Drug | N-(8-aminooctyl)-5-iodonaphthalene-1-sulfonamide | 2.51e-07 | 6 | 54 | 3 | CID000004307 | |
| Drug | propyl-methylenedioxyindene | 2.51e-07 | 6 | 54 | 3 | CID000145934 | |
| Drug | 1-(4-pyridyl)ethanol | 4.38e-07 | 7 | 54 | 3 | CID000090919 | |
| Drug | MS-857 | 4.38e-07 | 7 | 54 | 3 | CID000129517 | |
| Drug | SQ 65442 | 4.38e-07 | 7 | 54 | 3 | CID000128039 | |
| Drug | AC1L3PE4 | 4.38e-07 | 7 | 54 | 3 | CID000093048 | |
| Drug | AC1L52O2 | 4.38e-07 | 7 | 54 | 3 | CID000196983 | |
| Drug | O-4-(ethoxybutyl)berbamine | 4.38e-07 | 7 | 54 | 3 | CID000188375 | |
| Drug | chloronitromethane | 4.38e-07 | 7 | 54 | 3 | CID000074529 | |
| Drug | trifluoperazine sulfoxide | 4.38e-07 | 7 | 54 | 3 | CID000159622 | |
| Drug | TZC-5665 | 4.38e-07 | 7 | 54 | 3 | CID006449836 | |
| Drug | KHL-8430 | 4.38e-07 | 7 | 54 | 3 | CID000195711 | |
| Drug | CPU57 | 4.38e-07 | 7 | 54 | 3 | CID000195730 | |
| Drug | DyCl3 | 4.38e-07 | 7 | 54 | 3 | CID000066207 | |
| Drug | Drnflrfamide | 4.38e-07 | 7 | 54 | 3 | CID000132879 | |
| Drug | 4-hydroxyphenylglycol | 4.38e-07 | 7 | 54 | 3 | CID003081980 | |
| Drug | DAPpNP | 4.38e-07 | 7 | 54 | 3 | CID005492375 | |
| Drug | T 7188 | 4.38e-07 | 7 | 54 | 3 | CID000003311 | |
| Drug | asocainol | 4.38e-07 | 7 | 54 | 3 | CID000071161 | |
| Drug | 3,7,8-trihydroxy-CPZ | 7.00e-07 | 8 | 54 | 3 | CID000467415 | |
| Drug | proxyl nitroxide | 7.00e-07 | 8 | 54 | 3 | CID000076702 | |
| Drug | niludipine | 7.00e-07 | 8 | 54 | 3 | CID000089767 | |
| Drug | KS-504a | 7.00e-07 | 8 | 54 | 3 | CID000129577 | |
| Drug | NSP-805 | 7.00e-07 | 8 | 54 | 3 | CID000130349 | |
| Drug | Ro 22-4839 | 7.00e-07 | 8 | 54 | 3 | CID000065839 | |
| Drug | HT-74 | 7.00e-07 | 8 | 54 | 3 | CID000126681 | |
| Drug | 2,6-ANS | 7.00e-07 | 8 | 54 | 3 | CID002762570 | |
| Drug | AC1MJ4D0 | 7.00e-07 | 8 | 54 | 3 | CID003085362 | |
| Drug | sulfamide | 8.48e-07 | 31 | 54 | 4 | CID000082267 | |
| Drug | 3'-deoxy-ATP | 9.67e-07 | 32 | 54 | 4 | CID000001601 | |
| Drug | w66 | 1.05e-06 | 9 | 54 | 3 | CID006439460 | |
| Drug | 7,8-diOH-CPZ | 1.05e-06 | 9 | 54 | 3 | CID000159916 | |
| Drug | picumast | 1.05e-06 | 9 | 54 | 3 | CID000431850 | |
| Drug | 5-exo-hydroxycamphor | 1.05e-06 | 9 | 54 | 3 | CID000440017 | |
| Drug | adamantanone | 1.05e-06 | 9 | 54 | 3 | CID000064151 | |
| Drug | KS-505a | 1.05e-06 | 9 | 54 | 3 | CID003081782 | |
| Drug | 1-isoamyl-3-isobutylxanthine | 1.50e-06 | 10 | 54 | 3 | CID000152034 | |
| Drug | norchlorpromazine | 1.50e-06 | 10 | 54 | 3 | CID000062875 | |
| Drug | Kr I | 1.50e-06 | 10 | 54 | 3 | CID005288675 | |
| Drug | AC1L8MM4 | 1.50e-06 | 10 | 54 | 3 | CID000429016 | |
| Drug | Ins(1,3)P2 | 2.05e-06 | 11 | 54 | 3 | CID000128419 | |
| Drug | indolidan | 2.05e-06 | 11 | 54 | 3 | CID005284402 | |
| Drug | 1-(5-aminopentyl)-3-phenylthiourea | 2.05e-06 | 11 | 54 | 3 | CID003035524 | |
| Drug | 4-iodotamoxifen | 2.05e-06 | 11 | 54 | 3 | CID003037006 | |
| Drug | alpha-amyrin linoleate | 2.05e-06 | 11 | 54 | 3 | CID005318324 | |
| Drug | IQ-3 | 2.05e-06 | 11 | 54 | 3 | CID000028212 | |
| Drug | AC1Q5XN5 | 2.05e-06 | 11 | 54 | 3 | CID000190946 | |
| Drug | AC1L2NX7 | 2.05e-06 | 11 | 54 | 3 | CID000125056 | |
| Drug | rubrofusarin | 2.05e-06 | 11 | 54 | 3 | CID000072537 | |
| Drug | CV-159 | 2.73e-06 | 12 | 54 | 3 | CID000135211 | |
| Drug | NSC234486 | 2.73e-06 | 12 | 54 | 3 | CID000002674 | |
| Drug | AC1O3Q5W | 2.73e-06 | 12 | 54 | 3 | CID006334250 | |
| Drug | tiflucarbine | 2.73e-06 | 12 | 54 | 3 | CID000065677 | |
| Drug | Ant-dATP | 2.73e-06 | 12 | 54 | 3 | CID000131323 | |
| Drug | SC-9 | 3.26e-06 | 43 | 54 | 4 | CID000124172 | |
| Drug | PD140548 | 3.55e-06 | 13 | 54 | 3 | CID005311347 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 5.79e-07 | 10 | 51 | 3 | C1631597 | |
| Disease | Phencyclidine-Related Disorders | 6.12e-05 | 7 | 51 | 2 | C0236742 | |
| Disease | Phencyclidine Abuse | 6.12e-05 | 7 | 51 | 2 | C0031391 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 8.47e-05 | 49 | 51 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | Cannabis Abuse | 1.31e-04 | 10 | 51 | 2 | C0006868 | |
| Disease | Cannabis-Related Disorder | 1.31e-04 | 10 | 51 | 2 | C0236735 | |
| Disease | Hashish Abuse | 1.31e-04 | 10 | 51 | 2 | C0018614 | |
| Disease | glycerol-3-phosphate measurement | 3.03e-04 | 15 | 51 | 2 | EFO_0010488 | |
| Disease | Nonsyndromic genetic hearing loss | 3.13e-04 | 76 | 51 | 3 | cv:C5680182 | |
| Disease | Romano-Ward Syndrome | 3.46e-04 | 16 | 51 | 2 | C0035828 | |
| Disease | Cannabis Dependence | 3.92e-04 | 17 | 51 | 2 | C0006870 | |
| Disease | Brugada Syndrome (disorder) | 7.89e-04 | 24 | 51 | 2 | C1142166 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 1.03e-03 | 447 | 51 | 5 | EFO_0000694, MONDO_0100096 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 1.15e-03 | 29 | 51 | 2 | cv:C5779548 | |
| Disease | cardiac arrhythmia | 1.24e-03 | 30 | 51 | 2 | EFO_0004269 | |
| Disease | Marijuana Abuse | 1.24e-03 | 30 | 51 | 2 | C0024809 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DSEQEDERGAQDMDN | 716 | Q4LE39 | |
| DERGAQDMDNNGKEE | 721 | Q4LE39 | |
| DGEVNEVDMEGNEQD | 101 | P60006 | |
| EAELQDMINEVDADG | 46 | P0DP25 | |
| NGKDRGDEDQSREQM | 406 | Q9UBC3 | |
| TQNMERFGEDNLEDD | 371 | Q9UNH5 | |
| MSNLENDRDERDDDS | 1141 | Q5VU97 | |
| EAELQDMINEVDADG | 46 | P0DP24 | |
| EGADDRKENTMAENE | 836 | Q5T481 | |
| GDEDLRRQMQDDEQK | 66 | O75781 | |
| DDSDRENKGEDTEMQ | 331 | Q96ST2 | |
| QAGQDLEENMDEDIS | 256 | Q96RS6 | |
| TMAANESQEIDEDEG | 996 | Q13127 | |
| RENAERLMDDNDSEN | 141 | Q9UK17 | |
| SLEMENENLVENGAD | 671 | Q9UHB6 | |
| DLNGDGEVDMEEFEQ | 231 | Q9BPX6 | |
| DRDEMADEVANGNLS | 1726 | Q7Z406 | |
| ENVLGEDESSDDQDM | 196 | O43934 | |
| MAEGDAGSDQRQNEE | 1 | Q9P2X3 | |
| EDQQDADEDRRAFQM | 136 | Q8NB16 | |
| NEETQEREEQMKEGE | 461 | P49321 | |
| SGNEVSENMEEEAEN | 751 | P49321 | |
| SENMEEEAENQAESR | 756 | P49321 | |
| DQAENEGEDSAVLME | 536 | B5ME19 | |
| RQGMDLSANQDEETD | 276 | Q16658 | |
| EDDEMQHNEGQERSS | 101 | Q9UI42 | |
| MSQEGESEEENSQEE | 1506 | Q3T8J9 | |
| EAELQDMINEVDADG | 46 | P0DP23 | |
| SEDGAREQENMDDTN | 2436 | Q5TBA9 | |
| MDQEAQEQGKEDREG | 4196 | Q8NDH2 | |
| EEELQGDQAMQEDRA | 506 | Q9UKV0 | |
| EDAQIQEMESGEQAA | 556 | Q9UKV0 | |
| NDMDEQQNARESLED | 216 | Q8TB52 | |
| NQDETEDTELQGMNE | 1261 | Q14839 | |
| NMNDNFLEGEEENEL | 541 | P05060 | |
| MAEEAAQNISDDQER | 1 | Q8TDX9 | |
| DDNLELEMNSESENG | 896 | Q96PC5 | |
| DDDMSGDEKQDNESN | 1596 | Q93008 | |
| EGEENDDEDMQEERN | 1436 | O95602 | |
| NQNAETELMLEGDDD | 2121 | Q8NFP9 | |
| LDQDTQVQDMDEGSD | 346 | Q15459 | |
| ARENEMDENLEQVSG | 141 | P60880 | |
| DGEEKMEGNSQETER | 241 | Q16533 | |
| NEQMENTQRAEHEEG | 686 | O95025 | |
| DMERGNTQEDAADGE | 631 | Q0VD83 | |
| QEQAGREEAFNMDSA | 166 | Q5TG30 | |
| VDHNMDVNTEEDDDG | 661 | Q8NI35 | |
| MQEDEFDQGNQEQED | 256 | Q14515 | |
| QEQEDNSNAEMEEEN | 266 | Q14515 | |
| MESESTQDEQEEENG | 271 | A1A519 | |
| ELDGQQEMEDFEENA | 621 | Q8N1W2 | |
| NSQMEKDHNSEDEDE | 226 | O95391 | |
| QDEENQSMEGDEEDE | 841 | Q8WVM7 | |
| GNSVEELEEMDSQDA | 1196 | Q96JH7 | |
| QFEADMNEQDCLEDD | 136 | Q6UXN7 | |
| QREDEDGMANEDELD | 866 | Q5VYS8 | |
| DEEGQDDSQNEDSMD | 2356 | Q15911 | |
| MNAEEDSLRNGGEEE | 46 | Q13562 | |
| NGGQDEENSDQRDDM | 156 | Q96PU5 |